|
1
|
Khurana J, Abdul-Karim F and Bovée JVMG:
Osteochondroma. In: World Health Organization Classification of
Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone.
Fletcher CDM, Unni KK and Mertens F: IARC Press. (Lyon). 234–236.
2002.
|
|
2
|
Wicklund CL, Pauli RM, Johnston D and
Hecht JT: Natural history study of hereditary multiple exostoses.
Am J Med Genet. 55:43–46. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bovée JVMG and Hogendoorn PCW: Multiple
osteochondromas. In: World Health Organization Classification of
Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone.
Fletcher CDM, Unni KK and Mertens F: IARC Press. (Lyon). 360–362.
2002.
|
|
4
|
Hameetman L, Bovée JV, Taminiau AH, Kroon
HM and Hogendoorn PC: Multiple osteochondromas: Clinicopathological
and genetic spectrum and suggestions for clinical management. Hered
Cancer Clin Pract. 2:161–173. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu YQ, Heutink P, de Vries BB, Sandkuijl
LA, van den Ouweland AM, Niermeijer MF, Galjaard H, Reyniers E,
Willems PJ and Halley DJ: Assignment of a second locus for multiple
exostoses to the pericentromeric region of chromosome 11. Hum Mol
Genet. 3:167–171. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wuyts W, Ramlakhan S, Van Hul W, Hecht JT,
van den Ouweland AM, Raskind WH, Hofstede FC, Reyniers E, Wells DE
and de Vries B: Refinement of the multiple exostoses locus (EXT2)
to a 3-cM interval on chromosome 11. Am J Hum Genet. 57:382–387.
1995.PubMed/NCBI
|
|
7
|
Lüdecke HJ, Ahn J, Lin X, Hill A, Wagner
MJ, Schomburg L, Horsthemke B and Wells DE: Genomic organization
and promoter structure of the human EXT1 gene. Genomics.
40:351–354. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roychoudhury A, Bhatt K, Yadav R, Bhutia O
and Roychoudhury S: Review of osteochondroma of mandibular condyle
and report of a case series. J Oral Maxillofac Surg. 69:2815–2823.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huvos AG: Bone Tumors. Diagnosis,
Treatment and Prognosis (2nd). WB Saunders. (Philadelphia).
1991.
|
|
10
|
Mertens F, Rydholm A, Kreicbergs A, Willén
H, Jonsson K, Heim S, Mitelman F and Mandahl N: Loss of chromosome
band 8q24 in sporadic osteocartilaginous exostoses. Genes
Chromosomes Cancer. 9:8–12. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bridge JA, Nelson M, Orndal C, Bhatia P
and Neff JR: Clonal karyotypic abnormalities of the hereditary
multiple exostoses chromosomal loci 8q24.1 (EXT1) and 11p11-12
(EXT2) in patients with sporadic and hereditary osteochondromas.
Cancer. 82:1657–1663. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wuyts W, Van Hul W, De Boulle K, Hendrickx
J, Bakker E, Vanhoenacker F, Mollica F, Lüdecke HJ, Sayli BS,
Pazzaglia UE, et al: Mutations in the EXT1 and EXT2 genes in
hereditary multiple exostoses. Am J Hum Genet. 62:346–354. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wuyts W, Radersma R, Storm K and Vits L:
An optimized DHPLC protocol for molecular testing of the EXT1 and
EXT2 genes in hereditary multiple osteochondromas. Clin Genet.
68:542–547. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lonie L, Porter DE, Fraser M, Cole T, Wise
C, Yates L, Wakeling E, Blair E, Morava E, Monaco AP and Ragoussis
J: Determination of the mutation spectrum of the EXT1/EXT2 genes in
British Caucasian patients with multiple osteochondromas and
exclusion of six candidate genes in EXT negative cases. Hum Mutat.
27:11602006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pedrini E, De Luca A, Valente EM, Maini V,
Capponcelli S, Mordenti M, Mingarelli R, Sangiorgi L and
Dallapiccola B: Novel EXT1 and EXT2 mutations identified by DHPLC
in Italian patients with multiple osteochondromas. Hum Mutat.
26:2802005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jennes I, Pedrini E, Zuntini M, Mordenti
M, Balkassmi S, Asteggiano CG, Casey B, Bakker B, Sangiorgi L and
Wuyts W: Multiple osteochondromas: Mutation update and description
of the multiple osteochondromas mutation database (MOdb). Hum
Mutat. 30:1620–1627. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wuyts W and Van Hul W: Molecular basis of
multiple exostoses: Mutations in the EXT1 and EXT2 genes. Hum
Mutat. 15:220–227. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
McCormick C, Duncan G, Goutsos KT and
Tufaro F: The putative tumor suppressors EXT1 and EXT2 form a
stable complex that accumulates in the Golgi apparatus and
catalyzes the synthesis of heparan sulfate. Proc Natl Acad Sci USA.
97:668–673. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheung PK, McCormick C, Crawford BE, Esko
JD, Tufaro F and Duncan G: Etiological point mutations in the
hereditary multiple exostoses gene EXT1: A functional analysis of
heparan sulfate polymerase activity. Am J Hum Genet. 69:55–66.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hameetman L, David G, Yavas A, White SJ,
Taminiau AH, Cleton-Jansen AM, Hogendoorn PC and Bovée JV:
Decreased EXT expression and intracellular accumulation of HSPG in
osteochondromas and peripheral chondrosarcomas. J Pathol.
211:399–409. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Koziel L, Kunath M, Kelly OG and Vortkamp
A: Ext1-dependent heparan sulfate regulates the range of Ihh
signaling during endochondral ossification. Dev Cell. 6:801–813.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hameetman L, Rozeman LB, Lombaerts M,
Oosting J, Taminiau AH, Cleton-Jansen AM, Bovée JV and Hogendoorn
PC: Peripheral chondrosarcoma progression is accompanied by
decreased Indian Hedgehog (IHH) signalling. J Pathol. 209:501–511.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Benoist-Lasselin C, de Margerie E, Gibbs
L, Cormier S, Silve C, Nicolas G, LeMerrer M, Mallet JF, Munnich A,
Bonaventure J, et al: Defective chondrocyte proliferation and
differentiation in osteochondromas of MHE patients. Bone. 39:17–26.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hecht JT, Hall CR, Snuggs M, Hayes E,
Haynes R and Cole WG: Heparan sulfate abnormalities in exostosis
growth plates. Bone. 31:199–204. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bernard MA, Hall CE, Hogue DA, Cole WG,
Scott A, Snuggs MB, Clines GA, Lüdecke HJ, Lovett M, Van Winkle WB
and Hecht JT: Diminished levels of the putative tumor suppressor
proteins EXT1 and EXT2 in exostosis chondrocytes. Cell Motil
Cytoskeleton. 48:149–162. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hecht JT, Hogue D, Wang Y, Blanton SH,
Wagner M, Strong LC, Raskind W, Hansen MF and Wells D: Hereditary
multiple exostoses (EXT): Mutational studies of familial EXT1 cases
and EXT-associated malignancies. Am J Hum Genet. 60:80–86.
1997.PubMed/NCBI
|
|
27
|
Bovée JV, Cleton-Jansen AM, Wuyts W,
Caethoven G, Taminiau AH, Bakker E, Van Hul W, Cornelisse CJ and
Hogendoorn PC: EXT-mutation analysis and loss of heterozygosity in
sporadic and hereditary osteochondromas and secondary
chondrosarcomas. Am J Hum Genet. 65:689–698. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Esko JD and Selleck SB: Order out of
chaos: Assembly of ligand binding sites in heparan sulfate. Annu
Rev Biochem. 71:435–471. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Feely MG, Boehm AK, Bridge RS, Krallman
PA, Neff JR, Nelson M and Bridge JA: Cytogenetic and molecular
cytogenetic evidence of recurrent 8q24.1 loss in osteochondroma.
Cancer Genet Cytogenet. 137:102–107. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hameetman L, Szuhai K, Yavas A,
Knijnenburg J, van Duin M, van Dekken H, Taminiau AH, Cleton-Jansen
AM, Bovée JV and Hogendoorn PC: The role of EXT1 in nonhereditary
osteochondroma: Identification of homozygous deletions. J Natl
Cancer Inst. 99:396–406. 2007. View Article : Google Scholar : PubMed/NCBI
|
